NCM·Healthcare·$568M·#229 / 520 in Healthcare
PROK ProKidney Corp.
48SPECULATIVE
CATEGORY BREAKDOWN
GROWTH100
QUALITY0
STABILITY56
VALUATION0
GOVERNANCE75
METRIC BREAKDOWN
Revenue Growth (YoY)
Year-over-year revenue growth rate
+1075.0%
100
> 50% strong
Gross Margin
Revenue retained after direct costs
N/A
0
> 50% strong
Cash Runway
Months of cash at current burn rate
11 months
34
> 24 months ideal
Debt / Equity
Total debt relative to shareholder equity
-0.4%
100
< 25% strong
Price / Sales
Market cap relative to trailing revenue
636.4x
0
< 3x strong
Rule of 40
Growth rate plus operating margin
-17403
0
> 40 excellent
Insider Ownership
Percentage of shares held by insiders
24.4%
92
> 20% strong
Share Dilution (12M)
Share count increase over last 12 months
+9.6%
42
< 5% ideal
SCORE HISTORY
RELATED STOCKS
COMPARE PROK WITH…
OR QUICK-COMPARE SECTOR PEERS
SCORE ALERT
Get notified when PROK's score changes by 5+ points.
DATA INFO
Last updated: May 4, 2026
Sources: SEC EDGAR, Financial Modeling Prep, Yahoo Finance. Not financial advice.